Sarissa Capital Acquisition announced that it will redeem all of its outstanding Class A ordinary shares, effective Oct. 31 because the company will not complete the consummation of an initial business combination within deadline.
Sarissa raised $175 million in an October 2020 IPO with a focus on companies in the healthcare sector.
The SPAC in July had filed a proxy seeking a merger deadline extension from Oct. 23 to an indeterminate date in 2023. Read more.
